Gerald E. Van Strydonck - 11 May 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Gerald E. Van Strydonck
Issuer symbol
VCNX
Transactions as of
11 May 2023
Net transactions value
$0
Form type
4
Filing time
15 May 2023, 16:31:05 UTC
Previous filing
28 Nov 2022
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 67,232 11 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +143,848 $0.000000 143,848 11 May 2023 Common Stock 143,848 $0.4100 Direct F6
holding VCNX Stock Option (Right to Buy) 6,396 11 May 2023 Common Stock 6,396 $13.60 Direct F1
holding VCNX Stock Option (Right to Buy) 2,501 11 May 2023 Common Stock 2,501 $5.26 Direct F1
holding VCNX Stock Option (Right to Buy) 7,718 11 May 2023 Common Stock 7,718 $7.78 Direct F2
holding VCNX Stock Option (Right to Buy) 2,385 11 May 2023 Common Stock 2,385 $5.52 Direct F1
holding VCNX Stock Option (Right to Buy) 1,856 11 May 2023 Common Stock 1,856 $7.17 Direct F1
holding VCNX Stock Option (Right to Buy) 2,737 11 May 2023 Common Stock 2,737 $4.85 Direct F1
holding VCNX Stock Option (Right to Buy) 15,679 11 May 2023 Common Stock 15,679 $3.95 Direct F3
holding VCNX Stock Option (Right to Buy) 28,586 11 May 2023 Common Stock 28,586 $2.15 Direct F4
holding VCNX Stock Option (Right to Buy) 53,254 11 May 2023 Common Stock 53,254 $1.12 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable in full as of the date of this report.
F2 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F3 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F4 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F5 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F6 This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.